Drug Trial Radar · NCT02754765
Evaluating Newly Approved Drugs for Multidrug-resistant TB
Last checked: Nov 19, 2026Latest source record: Feb 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
754
Actual
Start
Dec 2016
Primary completion
Jun 2023
Study completion Jun 2023
Sponsor
- Lead sponsor
- Médecins Sans Frontières, FranceAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Partners in Health; Harvard Medical School (HMS and HSDM); Epicentre; Institute of Tropical Medicine, Belgium; Socios En Salud, Peru; Interactive Research and Development
- First posted
- Apr 28, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
endTB Clinical Trial a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of five new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB).
Conditions
- Tuberculosis, Multidrug-Resistant
- Infection, Bacterial
- Pulmonary Tuberculoses
Interventions
BedaquilineDrug
DelamanidDrug
ClofazimineDrug
LevofloxacinDrug
MoxifloxacinDrug
LinezolidDrug
PyrazinamideDrug
Control arm MDR-TB regimen, consistent with WHO guidelinesDrug
Control arm MDR-TB regimen, consistent WHO guidelines
Primary outcomes
What the sponsor says the trial is designed to measure.
- Week 73 EfficacyTime frame: Week 73 after randomization
Locations
12 sites in 7 countries. Site status is shown where the registry gives one.
National Center for Tuberculosis and Lung Diseases
Tbilisi, Georgia
Aundh Chest Hospital
Pune, India
City Centre of Phthisiopulmonology
Almaty, Kazakhstan
Center of Phthisiopulmonology of Almaty Health Department
Almaty, Kazakhstan
National Center for Tuberculosis Problems
Almaty, Kazakhstan
Partners In Health Lesostho
Maseru, Lesotho
The Indus Hospital
Karachi, Pakistan
Institute of Chest Disease,
Kotri, Pakistan
Centro de Investigación del Hospital Nacional Hipólito Unanue
Lima, Peru
Centro de Investigación de Enfermedades Neumológicas del Hospital Nacional Sergio Bernales
Lima, Peru
Hospital Nacional Dos de Mayo Parque Historia de la Medicina
Lima, Peru
Medecins Sans Frontieres Belgium
Khayelitsha, South Africa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.